Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DEXLANSOPRAZOLE SESQUIHYDRATE [ROUTE CODE - "DP"], with a corresponding US DMF Number 24815.
Remarkably, this DMF maintains an Active status since its submission on April 01, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 20, 2016, and payment made on July 01, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II